PharmaSynergy 2021

On behalf of #Lynx2Market – we would like to thank all attendees of the #PharmaSynergy 2021 that took place on February 23-25. We were thrilled to host & connect 160+ #BusinessDevelopment & #Licensing professionals from 46 countries.

Why join PharmaSynergy?

Whether you joined us to understand where the generics industry is heading, to learn about BD opportunities in #pharmerging and #mature markets or to arrange for the #partnering_meetings with new and established BD peers – #PharmaSynergy is your go-to event for #Business_Development & Licensing. 

What about 1-2-1 partnering?

1. High-level partnering meetings with senior BD executives.
With 12% - CEO/MD/GM, 47% - SVP/ Head of BD and 38% - BD Manager – your conversations convert into an actual business.

2. Broad-spectrum of product portfolio for both In & Out-Licensing conversations

3. Efficient partnering structure (whether it is "live or digital"); a carefully composed profile-matching mechanism based on key sector-driven criteria allows for efficient and targeted partnering conversations.

4. Truly international B2B platform: your partnering opportunity with key players from Europe, Africa, LATAM and MENA.

88.43% of our attendees thought PharmaSynergy’s digital edition was “Great"

This PharmaSynergy edition was exceptional, I have just finished my scheduled meetings, and have lots of excellent leads, creative ideas and relations with wonderful industry colleagues, more than I have expected and had in previous editions.

- SAJA Pharmaceuticals (Saudi Arabia)

It was a great event, congratulations! There were fantastic companies attending and very interesting speakers.

- Reig Jofre (Spain)

“The meetings were really helpful and the platform was easy to manage and help to find the correct contacts”.

- Carnot Laboratories (Mexico)

Watch the Highlights of the BD&Licensing discussion that took place at #PharmaSynergy 2021

If you haven’t had a chance to join – request videos and presentations.

How to ensure you don't miss the next event?